Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bukowski

Showing results (11-20 of 357) with videos related to

Pageof 36
Sort By:
Seminars in Oncology|April 18, 2000
Cytokine combinations: therapeutic use in patients with advanced renal cell carcinomaR M Bukowski
International Journal of Colorectal Disease|June 1, 1987
Clinical trials in colorectal cancer: experience of the Gastrointestinal Tumor Study Group and the Southwest Oncology GroupR M Bukowski
Cancer Management and Research|December 29, 2010
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumabRonald M Bukowski
Frontiers in Oncology|June 2, 2012
Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinomaRonald M Bukowski
Seminars in Urologic Oncology|May 17, 2001
Cytokine therapy for metastatic renal cell carcinomaR M Bukowski
Seminars in Oncology|August 1, 1994
Biologic therapy in patients receiving salvage treatmentR M Bukowski
Oncology (Williston Park, N.Y.)|June 23, 1999
Immunotherapy in renal cell carcinomaRonald M Bukowski
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
The need for cytoprotectionR M Bukowski
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Amifostine (Ethyol): dosing, administration and patient management guidelinesR M Bukowski
Clinical Genitourinary Cancer|November 7, 2009
What role do combinations of interferon and targeted agents play in the first-line therapy of metastatic renal cell carcinoma?Ronald M Bukowski
Pageof 36

Showing results (11-20 of 357) with videos related to

Sort By:
Pageof 36
Seminars in Oncology|April 18, 2000
Cytokine combinations: therapeutic use in patients with advanced renal cell carcinomaR M Bukowski
International Journal of Colorectal Disease|June 1, 1987
Clinical trials in colorectal cancer: experience of the Gastrointestinal Tumor Study Group and the Southwest Oncology GroupR M Bukowski
Cancer Management and Research|December 29, 2010
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumabRonald M Bukowski
Frontiers in Oncology|June 2, 2012
Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinomaRonald M Bukowski
Seminars in Urologic Oncology|May 17, 2001
Cytokine therapy for metastatic renal cell carcinomaR M Bukowski
Seminars in Oncology|August 1, 1994
Biologic therapy in patients receiving salvage treatmentR M Bukowski
Oncology (Williston Park, N.Y.)|June 23, 1999
Immunotherapy in renal cell carcinomaRonald M Bukowski
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
The need for cytoprotectionR M Bukowski
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Amifostine (Ethyol): dosing, administration and patient management guidelinesR M Bukowski
Clinical Genitourinary Cancer|November 7, 2009
What role do combinations of interferon and targeted agents play in the first-line therapy of metastatic renal cell carcinoma?Ronald M Bukowski
Pageof 36